Cargando…
Targeting tRNA-synthetase interactions towards novel therapeutic discovery against eukaryotic pathogens
The development of chemotherapies against eukaryotic pathogens is especially challenging because of both the evolutionary conservation of drug targets between host and parasite, and the evolution of strain-dependent drug resistance. There is a strong need for new nontoxic drugs with broad-spectrum a...
Autores principales: | Kelly, Paul, Hadi-Nezhad, Fatemeh, Liu, Dennis Y., Lawrence, Travis J., Linington, Roger G., Ibba, Michael, Ardell, David H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046186/ https://www.ncbi.nlm.nih.gov/pubmed/32106219 http://dx.doi.org/10.1371/journal.pntd.0007983 |
Ejemplares similares
-
Aminoacyl-tRNA synthetases
por: Rubio Gomez, Miguel Angel, et al.
Publicado: (2020) -
Aminoacyl-tRNA synthetases as drug targets in eukaryotic parasites()
por: Pham, James S., et al.
Publicado: (2013) -
Structural conservation of an ancient tRNA sensor in eukaryotic glutaminyl-tRNA synthetase
por: Grant, Thomas D., et al.
Publicado: (2012) -
Structural Basis for the Antibiotic Resistance of Eukaryotic
Isoleucyl-tRNA Synthetase
por: Chung, Scisung, et al.
Publicado: (2020) -
Fine-Tuning of Alanyl-tRNA Synthetase Quality Control Alleviates Global Dysregulation of the Proteome
por: Kelly, Paul, et al.
Publicado: (2020)